Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by cboQcon Jan 10, 2011 9:48am

174 Views

Post# 17947408

RE: Halted !!

Sirona Biochem halted at 6:48 a.m. PT
Ticker Symbol: C:SBM
Sirona Biochem halted at 6:48 a.m. PT
Sirona Biochem Corp (C:SBM)
Shares Issued 38,078,667
Last Close 1/7/2011
.67
Monday January 10 2011 - Halt Trading
Sirona Biochem Corp. was halted at 6:48 a.m. PT on Jan. 10,2011, at the company's request, pending news.

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading